Comparison of the urate lowering effects of allopurinol and diflunisal
- PMID: 3599002
Comparison of the urate lowering effects of allopurinol and diflunisal
Abstract
The urate lowering effect of diflunisal, a fluorinated salicylate with an antiinflammatory action, was compared with that of allopurinol in a crossover study. When patients took diflunisal the mean serum urate was significantly greater than on allopurinol but still was within the optimal range in 6 of 8 patients studied. This effect was consistent with its uricosuric action. No inhibition of xanthine oxidase activity by diflunisal was found. Diflunisal could be particularly useful in patients who require a drug with both a uricosuric and an antiinflammatory effect.
Similar articles
-
Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies.J Rheumatol. 1984 Jun;11(3):330-2. J Rheumatol. 1984. PMID: 6547486
-
[The uric acid-lowering effect of diflunisal].Wien Klin Wochenschr. 1987 Nov 20;99(22):791-3. Wien Klin Wochenschr. 1987. PMID: 3433782 German.
-
[Hypouricemic effect of diflunisal in patients with gout].Cas Lek Cesk. 1986 Nov 14;125(46):1409-11. Cas Lek Cesk. 1986. PMID: 3815465 Czech. No abstract available.
-
Update on emerging urate-lowering therapies.Curr Opin Rheumatol. 2009 Mar;21(2):143-9. doi: 10.1097/BOR.0b013e328325bd94. Curr Opin Rheumatol. 2009. PMID: 19339925 Review.
-
Treatment of gout.N Engl J Med. 1971 Dec 2;285(23):1303-6. doi: 10.1056/NEJM197112022852306. N Engl J Med. 1971. PMID: 4941493 Review. No abstract available.
Cited by
-
Allopurinol for chronic gout.Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD006077. doi: 10.1002/14651858.CD006077.pub3. Cochrane Database Syst Rev. 2014. PMID: 25314636 Free PMC article.